Target intelligence / Profile preview

V-set and transmembrane domain-containing protein 5 (VSTM5)

Target
VSTM5
Molecular classification
Cell adhesion molecule, Immunoglobulin superfamily protein, Type I integral membrane protein, Putative immune checkpoint
01

Overview

V-set and transmembrane domain-containing protein 5 (VSTM5) is a member of the immunoglobulin superfamily expressed predominantly in the central nervous system, where it regulates neuronal morphogenesis, dendritic complexity, and synapse formation through its cell adhesion-like properties. VSTM5 is an N-linked glycosylated type I membrane protein that modulates both structural and functional aspects of neuron development. Additionally, VSTM5 has emerged as a novel immune checkpoint, closely related to proteins such as VISTA and TIGIT, with capabilities to suppress T-cell proliferation, induce regulatory T cells, and promote antigen-specific tolerance. Its involvement in neuronal development implicates it in disorders such as major depressive disorder and other neuropsychiatric conditions, while its immune regulatory functions position it as a potential therapeutic target for tolerance-based approaches in treating autoimmune diseases. No drug interactions or clinical biomarker applications have been described to date.

Other names
C11orf90LOC387804VSTM5V-set and transmembrane domain-containing protein 5V-set and transmembrane domain containing 5
02

Biological functions

Cell adhesion in the central nervous systemNeuronal morphogenesis (formation of dendrites, dendritic spines, filopodia)Regulation of neuronal migration during brain developmentModulation of synaptogenesis (excitatory synapse assembly)Positive regulation of filopodium assemblyRegulation of immune responses (inhibits T-cell proliferation, induces T-cell apoptosis, promotes regulatory T cell induction, maintenance of T-cell anergy)
03

Disease associations

Major depressive disorder (modulates neural circuits relevant to psychiatric disorders)Schizoid personality disorder and avoidant personality disorder (gene associations)Autoimmune diseases (role as immune checkpoint may be relevant to tolerance-based therapies)

Beyond the preview

Go deeper on V-set and transmembrane domain-containing protein 5 (VSTM5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-set and transmembrane domain-containing protein 5 (VSTM5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call